CORRECTED-UPDATE 3-Roche's combo lymphoma treatment wins U.S. FDA approval
June 14, 2019 at 18:28 PM EDT
The U.S. Food and Drug Administration on Monday granted earlier-than-expected approval to Roche Holding AG's antibody- Polivy for treatment of patients with advanced lymphoma.
